Obinutuzumab (anti-CD20)

製品コード：A2023         Batch: A202301

印刷

Obinutuzumab (Gazyva, GA101, Gazyvaro, Afutuzumab) (anti-CD20) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin.

製品説明

CAS No. 949142-50-1
Formulation PBS buffer, pH 7.2
Isotype Human IgG1 isotype control
Source Humanized (from mouse)
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Purity 99.65%
Protein concentration 5 mg/ml
Endotoxin Level ≤1 EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。